Biodesix advances two complementary approaches to molecular residual disease (MRD) monitoring
BDSX•Biodesix said it is advancing two complementary approaches to molecular residual disease monitoring.
1. MRD monitoring
Biodesix said it is advancing two complementary approaches to molecular residual disease monitoring.
